Global Janus Kinase (JAK) Inhibitors Market 2022-2026

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publishers market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth. The publisher has been monitoring the Janus kinase (JAK) inhibitors market and it is poised to grow by $ 12.05 billion during 2022-2026, progressing at a CAGR of 17.24% during the forecast period. This report on the Janus kinase (JAK) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of awareness campaigns, application of JAK inhibitors in severe chronic indications, and support from the growing healthcare insurance industry. In addition, the increasing number of awareness campaigns is anticipated to boost the growth of the market as well.

The Janus kinase (JAK) inhibitors market analysis include Application and Geography segments.

The publisher's Janus kinase (JAK) inhibitors market is segmented as below:

By Application

Autoimmune disorders
Oncology

By Geographic

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of research grants as one of the prime reasons driving the Janus kinase (JAK) inhibitors market growth during the next few years. Also, special drug designations and rising number of strategic alliances will lead to sizable demand in the market.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on Janus kinase (JAK) inhibitors market covers the following areas:

Janus kinase (JAK) inhibitors market sizing
Janus kinase (JAK) inhibitors market forecast
Janus kinase (JAK) inhibitors market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Janus kinase (jJAKk) inhibitors market vendors that include AbbVie Inc., Alexion Pharmaceuticals Inc., Astellas Pharma Inc., AstraZeneca Plc, Bristol Myers Squibb Co., CTI BioPharma Corp., Eli Lilly and Co., Galapagos NV, Gilead Sciences Inc., Incyte Corp., Novartis AG, Pfizer Inc., Reistone Biopharma Co. Ltd., Sierra Oncology Inc., and Teva Pharmaceutical Industries Ltd. Also, the Janus kinase (JAK) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Autoimmune disorders - Market size and forecast 2021-2026
Exhibit 28: Chart on Autoimmune disorders - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Autoimmune disorders - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Autoimmune disorders - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Autoimmune disorders - Year-over-year growth 2021-2026 (%)
5.4 Oncology - Market size and forecast 2021-2026
Exhibit 32: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Application
Exhibit 36: Market opportunity by Application ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 France - Market size and forecast 2021-2026
Exhibit 70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on France - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 85: AbbVie Inc. - Overview
Exhibit 86: AbbVie Inc. - Business segments
Exhibit 87: AbbVie Inc. - Key offerings
Exhibit 88: AbbVie Inc. - Segment focus
10.4 Astellas Pharma Inc.
Exhibit 89: Astellas Pharma Inc. - Overview
Exhibit 90: Astellas Pharma Inc. - Product / Service
Exhibit 91: Astellas Pharma Inc. - Key news
Exhibit 92: Astellas Pharma Inc. - Key offerings
10.5 AstraZeneca Plc
Exhibit 93: AstraZeneca Plc - Overview
Exhibit 94: AstraZeneca Plc - Product / Service
Exhibit 95: AstraZeneca Plc - Key news
Exhibit 96: AstraZeneca Plc - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 97: Bristol Myers Squibb Co. - Overview
Exhibit 98: Bristol Myers Squibb Co. - Product / Service
Exhibit 99: Bristol Myers Squibb Co. - Key offerings
10.7 CTI BioPharma Corp.
Exhibit 100: CTI BioPharma Corp. - Overview
Exhibit 101: CTI BioPharma Corp. - Product / Service
Exhibit 102: CTI BioPharma Corp. - Key offerings
10.8 Eli Lilly and Co.
Exhibit 103: Eli Lilly and Co. - Overview
Exhibit 104: Eli Lilly and Co. - Business segments
Exhibit 105: Eli Lilly and Co. - Key offerings
Exhibit 106: Eli Lilly and Co. - Segment focus
10.9 Galapagos NV
Exhibit 107: Galapagos NV - Overview
Exhibit 108: Galapagos NV - Business segments
Exhibit 109: Galapagos NV - Key offerings
Exhibit 110: Galapagos NV - Segment focus
10.10 Incyte Corp.
Exhibit 111: Incyte Corp. - Overview
Exhibit 112: Incyte Corp. - Business segments
Exhibit 113: Incyte Corp. - Key offerings
Exhibit 114: Incyte Corp. - Segment focus
10.11 Novartis AG
Exhibit 115: Novartis AG - Overview
Exhibit 116: Novartis AG - Business segments
Exhibit 117: Novartis AG - Key offerings
Exhibit 118: Novartis AG - Segment focus
10.12 Pfizer Inc.
Exhibit 119: Pfizer Inc. - Overview
Exhibit 120: Pfizer Inc. - Product / Service
Exhibit 121: Pfizer Inc. - Key news
Exhibit 122: Pfizer Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 123: Inclusions checklist
Exhibit 124: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 125: Currency conversion rates for US$
11.4 Research methodology
Exhibit 126: Research methodology
Exhibit 127: Validation techniques employed for market sizing
Exhibit 128: Information sources
11.5 List of abbreviations
Exhibit 129: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026
Exhibits 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Application - Market share 2021-2026 (%)
Exhibits 25: Data Table on Application - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Application
Exhibits 27: Data Table on Comparison by Application
Exhibits 28: Chart on Autoimmune disorders - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Autoimmune disorders - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Autoimmune disorders - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Autoimmune disorders - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Oncology - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Application ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: AbbVie Inc. - Overview
Exhibits 86: AbbVie Inc. - Business segments
Exhibits 87: AbbVie Inc. - Key offerings
Exhibits 88: AbbVie Inc. - Segment focus
Exhibits 89: Astellas Pharma Inc. - Overview
Exhibits 90: Astellas Pharma Inc. - Product / Service
Exhibits 91: Astellas Pharma Inc. - Key news
Exhibits 92: Astellas Pharma Inc. - Key offerings
Exhibits 93: AstraZeneca Plc - Overview
Exhibits 94: AstraZeneca Plc - Product / Service
Exhibits 95: AstraZeneca Plc - Key news
Exhibits 96: AstraZeneca Plc - Key offerings
Exhibits 97: Bristol Myers Squibb Co. - Overview
Exhibits 98: Bristol Myers Squibb Co. - Product / Service
Exhibits 99: Bristol Myers Squibb Co. - Key offerings
Exhibits 100: CTI BioPharma Corp. - Overview
Exhibits 101: CTI BioPharma Corp. - Product / Service
Exhibits 102: CTI BioPharma Corp. - Key offerings
Exhibits 103: Eli Lilly and Co. - Overview
Exhibits 104: Eli Lilly and Co. - Business segments
Exhibits 105: Eli Lilly and Co. - Key offerings
Exhibits 106: Eli Lilly and Co. - Segment focus
Exhibits 107: Galapagos NV - Overview
Exhibits 108: Galapagos NV - Business segments
Exhibits 109: Galapagos NV - Key offerings
Exhibits 110: Galapagos NV - Segment focus
Exhibits 111: Incyte Corp. - Overview
Exhibits 112: Incyte Corp. - Business segments
Exhibits 113: Incyte Corp. - Key offerings
Exhibits 114: Incyte Corp. - Segment focus
Exhibits 115: Novartis AG - Overview
Exhibits 116: Novartis AG - Business segments
Exhibits 117: Novartis AG - Key offerings
Exhibits 118: Novartis AG - Segment focus
Exhibits 119: Pfizer Inc. - Overview
Exhibits 120: Pfizer Inc. - Product / Service
Exhibits 121: Pfizer Inc. - Key news
Exhibits 122: Pfizer Inc. - Key offerings
Exhibits 123: Inclusions checklist
Exhibits 124: Exclusions checklist
Exhibits 125: Currency conversion rates for US$
Exhibits 126: Research methodology
Exhibits 127: Validation techniques employed for market sizing
Exhibits 128: Information sources
Exhibits 129: List of abbreviations